These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 25656249
1. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study. Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P. J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249 [Abstract] [Full Text] [Related]
2. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis. Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV. Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634 [Abstract] [Full Text] [Related]
3. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues. Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y. J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004 [Abstract] [Full Text] [Related]
4. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease. Hojsak I, Mišak Z, Jadrešin O, Močić Pavić A, Kolaček S. Scand J Gastroenterol; 2015 May; 50(10):1208-13. PubMed ID: 25877164 [Abstract] [Full Text] [Related]
9. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study. Jun YK, Ji E, Yang HR, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H. Therap Adv Gastroenterol; 2024 Dec; 17():17562848241248321. PubMed ID: 38741927 [Abstract] [Full Text] [Related]
14. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy. Ong DE, Kamm MA, Hartono JL, Lust M. J Gastroenterol Hepatol; 2013 Oct; 28(10):1595-9. PubMed ID: 23662928 [Abstract] [Full Text] [Related]